Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging

doi:10.4254/wjh.v7.i20.2245

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 20

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9967)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-8) series.

Item

Count

PDF

428

WORD

403

HTML

4280

Figures (1-1)

315

Tables (1-8)

319

Sum=5745

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

590

Download

1153

Sum=1743

Publishing Process of This Article

Item

Count

Browse

1018

Download

1461

Sum=2479

Sep 18, 2015 (publication date) through Nov 25, 2024

Times Cited of This Article

Times Cited (8)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Sep 18, 2015; 7(20): 2245-2263
Published online Sep 18, 2015. doi: 10.4254/wjh.v7.i20.2245

Open in New Tab Full Size Figure Download Figure

Figure 1 An illustrative case showing discrepancies between subsequent criteria used to assess tumor response in a patient treated with sorafenib for hepatocellular carcinoma. HCC: Hepatocellular carcinoma; CT: Computed tomography; RECIST: Response evaluation criteria in solid tumors; mRECIST: Modified RECIST.

Citation: Bouattour M, Payancé A, Wassermann J. Evaluation of antiangiogenic efficacy in advanced hepatocellular carcinoma: Biomarkers and functional imaging. World J Hepatol 2015; 7(20): 2245-2263
URL: https://www.wjgnet.com/1948-5182/full/v7/i20/2245.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i20.2245